Results 61 to 70 of about 2,136 (251)

Sweet Syndrome Following SARS-CoV2 Vaccination

open access: yesVaccines, 2021
Vaccines are today considered one of the most effective means against the Sars-CoV-2 pandemic. The BNT162b2 vaccine by Pfizer/BioNTech has been massively administered throughout the globe; since its approval, a wide spectrum of cutaneous reactions has ...
Maria Efenesia Baffa   +6 more
doaj   +1 more source

Radiation-induced Sweet’s Syndrome in a Case of Breast Carcinoma

open access: yesClinical Dermatology Review
Sweet’s syndrome is a reactive dermatosis which usually presents as edematous papules and plaques, and very rarely vesicles. It is seen to be associated with various conditions such as autoimmune diseases, malignancy, infections, and drugs.
Mohan Kumar   +3 more
doaj   +1 more source

What Immunological Defects Predispose to Non-tuberculosis Mycobacterial Infections? [PDF]

open access: yes, 2017
Nontuberculous mycobacteria (NTM) are categorized as one of the large and diverse groups of environmental organisms which are abundant in water and soil.  NTM cause a variety of diseases in humans that mainly affect the lung.
Adcock, IM   +7 more
core  

Turmeric and curcumin: From traditional medicine to modern therapeutic applications

open access: yesJSFA reports, EarlyView.
Abstract Turmeric (Curcuma longa), a medicinal plant, has maintained its cultural and therapeutic significance over centuries in Ayurveda, Unani, and Traditional Chinese Medicine. However, novel formulations and delivery methods are being developed to address these challenges.
Azma Nadeem   +7 more
wiley   +1 more source

Hormones of thyroid gland in sera of rats treated with different dose of concentrated potassium iodine solutions [PDF]

open access: yes, 2010
Introduction Potassium iodine (KI) is used as a drug therapy for treating numerous diseases such as small-vessel vasculitis, erythema nodosum, vasculitis nodularis, Sweet's syndrome, tuberculosis and granulomatosis, and for iodized salt. At the same time,
Aritonović Jelena   +2 more
core   +1 more source

Dupilumab‐Related Adverse Events and Intolerance in Aspirin‐Exacerbated Respiratory Disease Patients

open access: yes
International Forum of Allergy &Rhinology, EarlyView.
Lancelot P. Herpin   +8 more
wiley   +1 more source

Clinical Features and Therapeutic Outcomes in Pyoderma Gangrenosum: A Prospective Cohort Study

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis highly associated with systemic comorbidities. Accurate diagnosis and treatment remain challenging due to its rarity and clinical mimickers. Objectives To evaluate demographic, clinical features and treatment outcomes in patients referred with suspected PG at a tertiary ...
David Croitoru   +13 more
wiley   +1 more source

Sweet’s syndrome and fistulizing Crohn’s disease: A case report

open access: yesSAGE Open Medical Case Reports, 2019
Sweet’s syndrome is a rare, acute febrile neutrophilic dermatosis sometimes associated with inflammatory diseases, infections, malignancies or the administration of pharmacotherapeutics. Very seldom, it occurs as an extraintestinal manifestation of Crohn’
Stefan T Siedlikowski, Julie D Lacroix
doaj   +1 more source

Motor neuronopathy associated with Adenocarcinoma of Esophagus [PDF]

open access: yes, 2004
Neurologic paraneoplastic syndromes (NPS) are remote neurologic effects, except metastasis, of systemic cancers. These are a rare group of disorders, commonly associated with small cell lung carcinoma (SCLC).1 Various NPS have been described, including ...
Khealani, Bhojo A   +2 more
core   +1 more source

Sweet Syndrome - A Review of Pathogenesis, Clinical Features, Diagnosis and Treatment [PDF]

open access: yes, 2023
Sweet syndrome is a rare, inflammatory, non-infectious skin disorder characterized by an acute onset of skin leasions such as painful, erythematous plaques, nodules and papules, most frequently located on the upper extremities, trunk, neck and face ...
Basiaga, Bartosz   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy